Solid Biosciences Inc (SLDB)
8.39
-0.12
(-1.41%)
USD |
NASDAQ |
May 22, 16:00
8.38
-0.01
(-0.12%)
After-Hours: 20:00
Solid Biosciences Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 8.094M |
Date | Value |
---|---|
December 31, 2021 | 13.62M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
8.094M
Minimum
2022
13.62M
Maximum
2021
10.86M
Average
10.86M
Median
Revenue (Annual) Benchmarks
Sarepta Therapeutics Inc | 1.243B |
PTC Therapeutics Inc | 937.82M |
Capricor Therapeutics Inc | 25.18M |
Catalyst Pharmaceuticals Inc | 398.20M |
Pfizer Inc | 58.50B |